Compare D Wave Quantum Inc (QBTS) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
D Wave Quantum Inc vs Zimmer Biomet Holdings Inc — how do they compare? D Wave Quantum Inc trades at $17.12 (market cap $6.38B), while Zimmer Biomet Holdings Inc trades at $94.73 (market cap $18.05B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 2.8× D Wave Quantum Inc's market cap, and Zimmer Biomet Holdings Inc pays a 1.01% dividend while D Wave Quantum Inc pays none. Which is the better fit depends on your goals.
| QBTS | ZBH | |
|---|---|---|
Market Cap | $6.38B | $18.05B |
Sector | Technology | Health |
52-Week High | $44.78 | $104.26 |
52-Week Low | $12.98 | $79.58 |
Enterprise Value | $5.88B | $25.11B |
Dividend Yield | — | 1.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
QBTS trades at $17.67, down 33% year-to-date, with a bearish technical signal and negative profitability metrics including a net income margin of -2,001.59% for 2026. Recent news highlights a $100 million U.S. government funding injection via the CHIPS Act, boosting sentiment amid ongoing losses and legal investigations.
The stock faces high risk from persistent losses and lofty valuations but holds long-term potential in quantum computing, supported by unanimous analyst buy ratings and a $37.00 consensus price target. Investors must weigh government backing against cash burn and competitive pressures in a nascent industry.
ZBH trades at $94.22, down 3.93% on the day, with a bearish technical signal but oversold RSI readings. Recent earnings beats and raised 2026 guidance support fundamentals, with revenue growth and strong gross margins. Leadership promotions aim to accelerate commercial transformation, while cash flow trends show operational strength.
The stock offers upside to the $104.88 consensus target, but faces headwinds from debt levels and competitive pressures. Near-term support at $92 is critical; a hold rating aligns with mixed analyst views. Earnings execution and procedure demand growth are key catalysts for valuation expansion.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About D Wave Quantum Inc
D-Wave Quantum Inc. is a global leader in the development and delivery of quantum computing systems, software, and services. The company specializes in annealing quantum computers designed to solve complex optimization problems across industries such as logistics, materials science, and financial modeling. D-Wave offers its technology through the cloud, allowing customers to build and run real-world quantum applications today, making it a key player in the commercialization of quantum computing.
Read more on QBTS →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
